Innovating antibodies, improving lives

Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.


Dec 3rd 260x1732018 ASH Data Review Meeting

Genmab hosted a 2018 R&D Update & ASH Data Review on December 3. You will be able to listen to an archived version of the webcast of the event by clicking here. Click here to download the slides. This meeting was not an official program of the ASH Annual meeting



Join our teamCareer Opportunities at Genmab

Genmab is seeking new employees to join our team. Visit our Careers webpages to explore current vacancies, learn about our culture and meet some of our team members. Click here to visit Genmab's page on LinkedIn.


shutterstock_310302614 (2)Genmab is on Twitter

Find Genmab on Twitter at @Genmab and @GenmabR_D